Phase IIThyroid Analog
Compound 61639
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061639
Risk Class
MODERATE
Last Audit
May 19, 2108
Research Abstract
Thyroid Analog candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61639 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase ii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061639 with updates logged 2108-05-19.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61639Thyroid Analog Program 61639
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061639
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61639